Does the frequency of diabetes increase in Covid-19 patients? cross-sectional study
Does the frequency of diabetes increase in Covid-19 patients? cross-sectional study
Objective: The aim of this study was to investigate frequency of diabetes mellitus (DM) in patients diagnosed with Covid-19 and whether Covid-19 had effect on high HbA1c.
Material-Methods: Data of DM patients with Covid-19 were analyzed cross-sectionally. In Covid-19, the effect of DM patient frequency and mortality was investigated.
Results: 2057 patients diagnosed with Covid-19 were included in the study. Among these patients, total 192 patients (9.25%) were treated with the diagnosis of DM. 73 (41 males-32 females) were newly diagnosed with DM (38.02%). 119 patients (48 males and 71 females) were previously diagnosed with DM. Eight of DM patients died. Among all Covid-19 in patients followed up, 90 patients died. Mortality of DM patients was not statistically significant compared to mortality of all patients (p=1.000 x=0). Of the patients who were followed up with diagnosis of DM, whose HbA1c were observed in the last 3 months, 16 of 20 patients had increase in HbA1c, and 4 patients had decrease in HbA1c. The mean increase was 1.05.
Conclusion: The frequency of new diagnosis DM in patients with Covid-19 was found to be quite high. There was increase in HbA1c in Covid-19 patients, and Covid-19 was thought to affect the pancreas.
Keywords:
Covid-19, Diabetes Mellitus, HbA1c ARDS, PCR,
___
- Covid-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Available from: https://coronavirus.jhu.edu/map.html.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507–13.
- Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in Covid-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020;14(4):303-10.
- Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574-81.
- Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med 2020)
- Docherty AB, Harrison EM, Green CA, et al. Features of 16,749 hospitalised UK patients with Covid-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv. 2020.https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1. Accessed 16 May 2020.
- Jaeckel E, Manns M, Herrath M (2006) Viruses and diabetes. Ann N Y Acad Sci 958:7–25
- Wan J, Sun W, Li X, Ying W, Dai J, Kuai X et al (2006) Infammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 6:2886–2894
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 2021
- Yayıncı: DAHUDER
Sayıdaki Diğer Makaleler
Bahadir ALAN, Latife KAYIKÇIOĞLU, İrmak SAYIN ALAN
Comparison of Cardiac Risk Factors in Patients with Nephrotic Syndrome and Secondary Amyloidosis
Osman CÜRE, Teslime AYAZ, Kuddusi CENGİZ
Does the frequency of diabetes increase in Covid-19 patients? cross-sectional study